Home Cart Sign in  
Chemical Structure| 501951-42-4 Chemical Structure| 501951-42-4

Structure of SB-705498
CAS No.: 501951-42-4

Chemical Structure| 501951-42-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SB-705498 is a selective antagonist of transient receptor potential vanilloid 1 (TRPV1) with pIC50 of 7.1.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SB-705498

CAS No. :501951-42-4
Formula : C17H16BrF3N4O
M.W : 429.23
SMILES Code : O=C(N[C@H]1CN(C2=NC=C(C(F)(F)F)C=C2)CC1)NC3=CC=CC=C3Br
InChI Key :JYILLRHXRVTRSH-GFCCVEGCSA-N
Pubchem ID :9910486

Safety of SB-705498

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H320-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00461682 Irritable Colon PHASE2 TERMINATED 2007-09-01 GSK Investigational Site, Lond... More >>on, W12 0NN, United Kingdom Less <<
NCT00269022 Migraine, Acute PHASE2 COMPLETED - GSK Investigational Site, Rand... More >>wick, New South Wales, 2031, Australia|GSK Investigational Site, Toronto, Ontario, M1L 4S4, Canada|GSK Investigational Site, Leiden, 2333 ZA, Netherlands|GSK Investigational Site, Cambridge, Cambridgeshire, CB2 2GG, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.33mL

0.47mL

0.23mL

11.65mL

2.33mL

1.16mL

23.30mL

4.66mL

2.33mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories